(Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -91.59%10.69K | -17.18%9.73K | -41.83%31.35K | 9.81%79.53K | 9.81%79.53K | 55.27%127.23K | -89.92%11.75K | -67.54%53.89K | -65.49%72.43K | -65.49%72.43K |
-Cash and cash equivalents | -91.59%10.69K | -17.18%9.73K | -41.83%31.35K | 9.81%79.53K | 9.81%79.53K | 55.27%127.23K | -89.92%11.75K | -67.54%53.89K | -65.49%72.43K | -65.49%72.43K |
Receivables | -57.22%2.41K | 123.47%6.64K | 127.68%13.7K | 27.14%6.72K | 27.14%6.72K | 18.49%5.63K | -12.08%2.97K | 162.89%6.02K | 463.22%5.28K | 463.22%5.28K |
-Accounts receivable | ---- | -39.16%1.81K | 127.68%13.7K | 27.14%6.72K | 27.14%6.72K | 18.49%5.63K | -12.08%2.97K | 162.89%6.02K | 463.22%5.28K | 463.22%5.28K |
-Taxes receivable | --2.41K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Due from related parties current | ---- | --4.83K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total current assets | -90.14%13.1K | 11.20%16.37K | -24.81%45.04K | 10.99%86.25K | 10.99%86.25K | 53.26%132.87K | -87.73%14.72K | -64.41%59.91K | -63.14%77.71K | -63.14%77.71K |
Non current assets | ||||||||||
Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total assets | -90.14%13.1K | 11.20%16.37K | -24.81%45.04K | 10.99%86.25K | 10.99%86.25K | 53.26%132.87K | -87.73%14.72K | -64.41%59.91K | -63.14%77.71K | -63.14%77.71K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | --82.98K | ---- | ---- | -30.60%3.94K | -30.60%3.94K | ---- | ---- | ---- | 93.25%5.67K | 93.25%5.67K |
-accounts payable | --74.62K | ---- | ---- | -30.60%3.94K | -30.60%3.94K | ---- | ---- | ---- | 93.25%5.67K | 93.25%5.67K |
-Due to related parties current | --8.37K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Current accrued expenses | --2.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Current liabilities | 209.35%85.48K | 421.02%34.48K | 214.41%14.07K | -30.60%3.94K | -30.60%3.94K | 396.89%27.63K | -57.19%6.62K | -73.14%4.48K | 93.25%5.67K | 93.25%5.67K |
Non current liabilities | ||||||||||
Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total liabilities | 209.35%85.48K | 421.02%34.48K | 214.41%14.07K | -30.60%3.94K | -30.60%3.94K | 396.89%27.63K | -57.19%6.62K | -73.14%4.48K | 93.25%5.67K | 93.25%5.67K |
Shareholders'equity | ||||||||||
Share capital | 0.00%543.31K | 58.26%543.31K | 58.26%543.31K | 58.26%543.31K | 58.26%543.31K | 58.26%543.31K | 4.36%343.31K | 4.36%343.31K | 4.36%343.31K | 4.36%343.31K |
-common stock | 0.00%543.31K | 58.26%543.31K | 58.26%543.31K | 58.26%543.31K | 58.26%543.31K | 58.26%543.31K | 4.36%343.31K | 4.36%343.31K | 4.36%343.31K | 4.36%343.31K |
Additional paid-in capital | 0.00%114.48K | 0.00%114.48K | 0.00%114.48K | 0.00%114.48K | 0.00%114.48K | 0.00%114.48K | -4.43%114.48K | -4.43%114.48K | -4.43%114.48K | -4.43%114.48K |
Retained earnings | -32.14%-730.17K | -50.30%-675.9K | -55.79%-626.82K | -49.18%-575.48K | -49.18%-575.48K | -46.70%-552.56K | -30.64%-449.69K | -35.43%-402.36K | -60.15%-385.75K | -60.15%-385.75K |
Total stockholders'equity | -168.78%-72.38K | -323.50%-18.11K | -44.13%30.97K | 14.26%82.31K | 14.26%82.31K | 29.70%105.23K | -92.25%8.1K | -63.45%55.43K | -65.35%72.04K | -65.35%72.04K |
Total equity | -168.78%-72.38K | -323.50%-18.11K | -44.13%30.97K | 14.26%82.31K | 14.26%82.31K | 29.70%105.23K | -92.25%8.1K | -63.45%55.43K | -65.35%72.04K | -65.35%72.04K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data